Xingqi was named to the “Top Employer China 2023” by 51jobs in January 2023. 

Xingqi was awarded the “Energy Management System Certificate” by the Ever Win Quality Certification Center in January 2023.

Sugaojie^®, a deproteinized calf blood extract eye gel developed by Xingqi, was recognized as the “Single-Item Champion Product in the Manufacturing Industry of Liaoning Province” in January 2023.

Shike^®, a compound electrolyte intraocular irrigating solution developed by Xingqi, was included in China’s national medical insurance catalog for 2023 on January 18, 2023. 

The Joint Innovation Center between Xingqi and Liaoning Institute of Industrial Technology was awarded the “2022 Advanced Branch of Liaoning Institute of Industrial Technology” on January 20, 2023.

The Party Committee of Xingqi was selected as the Party Building Demonstration Unit of Non-Public Enterprises in Liaoning Province by the Organization Department of the Liaoning Provincial Party Committee and the “Non-Public Economic Organization and Social Organization Working Committee of the Liaoning Provincial Party Committee” in February 2023. 

Newsun, chairman of Xingqi, was named to the “Excellent Private Entrepreneur Caring for Employees” by the All-China Federation of Industry and Commerce, the Ministry of Human Resources and Social Security and the All-China Federation of Trade Unions on February 21, 2023. 

Xingqi Technology Center was recognized as the 2022 (the 29th batch) National Enterprise Technology Center by the National Development and Reform Commission and the Ministry of Science and Technology of China on February 22, 2023. 

Xingqi was awarded the “Liaoning May 1st Labor Certificate” by Shenyang Federation of Trade Unions and the Ministry of Human Resources and Social Security Department of Liaoning Province in April 2023. 

Xingqi was awarded the “Party Building Demonstration Unit of Non-Public Enterprises in Liaoning Province Trophy” by the Party Committee of Hunnan District, Shenyang City, and the second party branch of Xingqi was selected as a recipient of the Rewards for the 2022 Non-Public Economic Organization and Social Organization Party Organization of Shenyang on April 14, 2023. 

Dikexin^®, a lysozyme eye drop developed by Xingqi, was presented the “Ophthalmic Products and Technological Progress Award” by the Ophthalmology Committee of China Association of Medical Equipment on April 27, 2023.

Xingqi won the “Best Small and Medium-Sized Investor Interaction Award” for the 2022 Panorama Investor Relations Gold Award on May 23, 2023.

Xingqi was presented the “14th Chinese Listed Companies Investor Relations Pegasus Award” by Securities Times on May 25, 2023. 

Xingqi was listed in the “2022 Top 100 Chinese Chemical Pharmaceutical Enterprises” in June 2023.

Xingqi participated in the Cataract Recovery Project in Zepu, Xinjiang, the 19th station of the “Bright Journey Along the Silk Road” Initiative launched by the “Charity Walk for Bright Vision Fund” of Shanghai Charity Foundation on June 13, 2023.

Xingqi was listed in the Famous Brands and the Most Popular Brands in Retail Drug Stores, Newsun, chairman of Xingqi, was named to the “Leader in the Pharmaceutical Industry” and Aierming^® with the red facial make-up packaging, a product of Xingqi, was listed in the “Most Popular Drug in Retail Drug Stores” at the 3rd China Pharmaceutical Industry Commerce and Trade Conference & the 3rd World Retail Pharmacy Conference (the “Star Pharmacy” 2023) on June 15, 2023.

Xingqi was named to the Top 50 Growth Enterprises in the Pharmaceutical Industry for 2022-2023 and the Law-abiding and Integrity-based Enterprises in the Pharmaceutical Industry by the Medical and Pharmaceutical Chamber of the All-China Federation of Industry and Commerce in July 2023.

Xingqi was elected a member of the Shenyang Popular Science Education-Based Alliance in July 2023.

Xingqi was awarded the second prize at the 11th National Brand Story Contest (Dalian Division) for the article “Focus on Goals, Put Quality First and Pursue Innovation-driven High-quality Development”in July 2023.

Xingqi was awarded four national pharmaceutical industry QC achievement awards at the 44th National Pharmaceutical Industry Quality Control (QC) Group Achievement Presentation and Exchange Conference in September 2023.

Xingqi joined the Aiding the Disabled Charity Program again and donated RMB 700,000 to the Shenyang Foundation for Disabled Persons in September 2023.

The Xingqi Student Aid Program was launched in Jimiao Middle School, Jiulong Town, Fuyang City, in September 2023.

Xingqi Children and Adolescents Myopia Prevention and Control Base was renamed Liaoning Province Science Education Base by the Department of Science & Technology of Liaoning Province and the Liaoning Association for Science and Technology in September 2023.

Xingqi was named to the 8th Batch of Exemplary Private Enterprises in Liaoning Province for the Establishment of a Modern Enterprise System by the Department of Industry and Information Technology of Liaoning Province in September 2023.

Xingqi was named to the Excellent Quality Management Promotion Base by the Liaoning Provincial Leading Group for Quality Empowerment in September 2023.

Xingqi was named to the Provincial Green Plant by the Department of Industry and Information Technology of Liaoning Province in September 2023.

Xingqi Aierming^® Sodium Hyaluronate Eye Drops was named to the Most Recommended Eye Care Product in Pharmacy in October 2023. Jiang Ning, Vice- President of the Marketing Center, was named to the 2023 China Pharmacy Pharmaceutical Marketing Gold Medal Trader in the same month.

Xingqi was presented the Golden Bull Award by the China Securities Journal in November 2023.

Xingqi came out on top in the assessment for the first batch of "zero-waste plants" in Shenyang on November 14, 2023.

The Party School Teaching Base of the Shenyang Hunnan District Committee of the Communist Party of China was established in Xingqi on November 17, 2023.

Newsun, Secretary of the Party Committee and Chairman of Xingqi, was named to the 2023 Influential Entrepreneurs at the 17th China Growth Pharmaceutical Enterprise Development Conference; Jiang Ning, Vice-President of the Marketing Center, was named to the 2023 Outstanding Young Leaders; and Xingqi was named to the 2023 Excellent Brands - Zirun^®Cyclosporine Eye Drops (Ⅱ) and the 2023 Pharmaceutical Brands from November 22 to 25, 2023.

Xingqi’s submission - “Focus on Goals, Put Quality First and Pursue Innovation-driven High-quality Development”- was awarded the third prize in the essay group by the China Association for Quality at the 2023 China Brand Innovation Conference in December 2023.

Shenzhen Stock Exchange announced a regular adjustment made to the sample stocks of SZSE Component Index, according to which Xingqi was selected as the sample stocks of the SZSE Component Index in December 2023.

Xingqi Zirun^® Cyclosporine Eye Drops (Ⅱ) as a NRDL-negotiated drug was renewed successfully and included in the 2023 National Reimbursement Drug List (NRDL) in December 2023.

Xingqi won the 20th National Quality Award at the China Association for Quality Annual Conference and the Second Global Excellence Conference on December 1, 2023.

Zirun^® Cyclosporine Eye Drops (Ⅱ) was named to the 2023 Excellent Biochemical and Biological Brand by the China Biochemical Pharmaceutical Industry Association on December 17, 2023.